Translational research editorial board

Back to the editorial board

To clinical research editorial board

Filter by field:

Sort by name:

Alessio Nocentini

Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, 50019 Florence, Italy

alessio.nocentini@unifi.it

Organic chemistry Drug design Enzyme modulators Enzymology GPCR Molecular dynamics Molecular modelling Spectroscopy Structure-based design

Alessio Nocentini is an academic researcher from the University of Florence. The author has contributed to research on topics such as: Carbonic Anhydrase modulators for treating cancer, inflammation, infections, ocular pathologies, and neurodegenerative diseases. The author has an H-index of 40, co-authored 215 publications receiving 5057 citations. 

Alexander TH Wu

The PhD Program of Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan

Clinical Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan

TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan

Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan

chaw1211@tmu.edu.tw

Cancer immunotherapies Cell-based therapies

Dr Wu received his Ph.D. (Anatomy and Cell Biology) from Queen's University, Kingston, Ontario, Canada. He currently an associate professor affiliated in several departments in Taipei Medical University: Graduate Institute of Biomedical Informatics; The Ph.D. Program for Translational Medicine. His research Interests primarily focus on the translational fronts. He deeply involved in exploring agents that target cancer-stem like cells (CSCs) and profiling the genes or networks involved in the generation and maintenance of these CSCs across various cancer types. He also have a keen interest in the fields of cancer immunotherapies, cell-based therapies for tissue regeneration, and applications of extracellular vesicles derived from mesenchymal stem cells.

Arnold Spek

Center of Experimental and Molecular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands

c.a.spek@amsterdamumc.nl

Oncology Biology Molecular and cell biology

Dr. Arnold Spek is an Associate Professor, Academisch Medisch Centrum Universiteit van Amsterdam, Center for Experimental and Molecular Medicine. His research interests focus on these areas: 1) Protease activated receptors and macrophages in pulmonary fibrosis. 2) Protease activated receptor 1 in cell fate decesions. 3) C/EBPdelta: master regulator of pancreatic cancer progression. 4) Mesoporous silica nanoparticles as drug carriers in pancreatic cancer.

Bjoern Petri

Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

bpetri@ucalgary.ca

Immunology Molecular and cell biology

Dr. Petri is the Scientific Director of the Mouse Phenomics Resource Laboratory since January 2011. He obtained his PhD (Dr. rer. nat.) in Immunology/Cell Biology and Genetics from the Westfalian Wilhelms-University and the Max-Planck-Institute for Molecular Biomedicine in Münster, Germany. He can look back at over 20 years of in vivo experience working with rodent models in the field of physiology and immunology.

Between 2007 and 2010 he worked as a Postdoctoral Fellow (AHFMR/AIHS) in the Snyder Institute for Chronic Diseases where he continued to strengthen his expertise in the field of Immunology and its related research models and imaging techniques.

Can Ince

Department of Intensive Care, Erasmus MC, Rotterdam, the Netherlands

c.ince@erasmusmc.nl

Anesthesiology Intensive care medicine Physiology

Professor Dr. Can Ince is a physiologist who heads the Department of Translational Physiology at the Academic Medical Center (AMC) of the University of Amsterdam. Together with his team he conducts both experimental and clinical research directed at cardiovascular aspects of peri-operative medicine. Research topics include clinical microcirculation research in intensive care, cardiothoracic surgery and anesthesiology, blood transfusion, fluid resuscitation, sepsis, shock and resuscitation, acute renal failure, oxygen transport to tissue and mitochondrial function. He is on the editorial boards of several journals and he has authored close to 300 scientific peer reviewed papers.

Chien-Feng Li

Department of Medical Research, Chi-Mei Medical Center, Tainan 710, Taiwan

angelo.p@yahoo.com.tw

Cancer biology Cancer cells Cancer diagnostics Immunohistochemistry Metastasis Oncogenes Prognostic markers Tumors

Dr. Li is the Chair of Department of Pathology, Chi Mei Medical Center, and he also serves as a professor at Southern Taiwan University of Science and Technology, as well as a joint-appointment associate investigator at National Institute of Cancer Research (Taiwan). His current research interest is integrative analysis of genetic, epigenetic, and expression alternations during cancer progression and metastasis, with special emphasis on sarcomas and therapy-resistant cancers. With the opportunities to integrate large-scaled clinical samples and advanced functional evaluations, he has been more focused on potential therapeutic opportunities of oncogenic metabolic transformations and the mechanisms how the metabolic characters of cancer implicate tumor progression.

Daniele Tibullo

Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy

d.tibullo@unict.it

Biodiversity Cancer biology Clinical hematology Flow cytometry Hematologic diseases Lymphoma Marine biology Osteoporosis

Dr. Daniele Tibullo is a Professor in the Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy. He completed his PhD in presso Division of Haematology, AOU "Policlinico - Vittorio Emanuele", University of Catania, Catania, Italy. With broad research interests in Cancer Biology, Lymphoma, Biodiversity, Marine Biology, Hematologic Diseases, Flow Cytometry, Clinical Hematology, Osteoporosis, Cell Proliferation, Cells. The research activity of Prof. Tibullo since the beginning of his career has focused on the role of heme oxygenase 1 and on the mechanisms connected to iron metabolism and the interaction between tumor cells and immune cells. In his scientific production, studies on the metabolic consequences in response to treatments and in the mechanisms of resistance to therapy have particular importance, with particular reference to the metabolic fitness of solid and hematological tumors. The research activity of Prof. Tibullo was primarily focused on preclinical research in mouse and zebrafish models and in vitro using human and mouse cell models. Among the most significant lines of research, studies on the antioxidant and anti-inflammatory role of alpha lipoic acid have a prominent place. The studies led by Prof. Tibullo, in synergy with authoritative colleagues of international standing and foreign institutions, have implications of both a strictly biochemical type and of a translational and clinical nature. Prof. Tibullo developed his scientific interests in the metabolic processes involved in the transformation of the tumor microenvironment, studying mitochondrial trafficking phenomena between different cell populations and the role of lactate metabolism in terms of cellular energy expenditure and signal molecule, in order to determine a remodeling of the biochemical processes of tumor, stromal and immune cells that make up the tumor microenvironment.

Edward Chouchani

Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA, USA

echouchani@gmail.com

Metabolism and metabolic diseases Oncology

Dr. Edward Chouchani joined the faculty of Harvard Medical School as an Assistant Professor of Cell Biology in 2017. He received his Ph.D. in Biological Sciences at the University of Cambridge and MRC Mitochondrial Biology Unit. He then performed postdoctoral research at the Dana-Farber Cancer Institute and Harvard Medical School. Research in the Chouchani Lab focuses on deciphering molecular mechanisms that drive metabolic disease, and using this information to develop targeted therapeutic strategies. The Chouchani Lab combines mass spectrometry and targeted pharmacological approaches in vivo to understand how mitochondrial redox metabolism controls physiology in clinically informative mouse models of obesity and diabetes.

Eleonore Fröhlich

Center for Medical Research, Medical University of Graz, Graz, Austria

eleonore.froehlich@medunigraz.at

Apoptosis Cancer biology Cell culture Immunocytochemistry Microscopy Nanoparticles Pharmacy Screening

Dr. Eleonore Fröhlich is a biochemist and a Medical Doctor with specialization in Anatomy, Histology and Embryology. Her current affiliations include the Medical University of Graz (Director of the Core Facility Imaging at the Center for Medical Research), the University Tübingen (extraordinary professor at the Institute of Anatomy) and the Research Center Pharmaceutical Engineering (Key researcher). Her research activities aim to link basic science and clinical research by using physiologically relevant 2D and 3D cell culture and various cellular readout parameters. Of particular interest is the assessment of the effects of inhaled pharmaceutical and environmental particles on the respiratory system. Expertise is also present in thyroid diseases and cancer.

Enrico Mastrobattista

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands

e.mastrobattista@uu.nl

Drug delivery Nanomedicine

Professor Enrico Mastrobattista, full professor of Pharmaceutical Biotechnology & Delivery at the department of Pharmaceutical Sciences of Utrecht University. Prof. Mastrobattista’s expertise lies in drug delivery, pharmaceutical biotechnology and nanobiotechnology. He currently leads a research program to develop biomimetic drug delivery systems for the targeted delivery of proteins, peptides and nucleic acids at the nano-scale. Prof. Mastrobattista has published over 120 scientific articles, contributed to several book chapters in pharmaceutical biotechnology, and holds several patents to his name. He has received a Vici and Vidi grant and has been awarded the prestigious Prix Galien Research Award for his work on drug delivery.

Eric Eldering

Cancer Center Amsterdam (CCA), Cancer Biology and Immunology, Target & Therapy Discovery, Amsterdam, the Netherlands

e.eldering@amsterdamumc.nl

Immunology Oncology

Dr. Eric Eldering was trained as molecular biologist/biochemist at the University of Amsterdam (PhD 1992). His research group at the Department of Experimental Immunology was formed in 2002, and he became Professor of Molecular Immuno-Hematology in 2012. Initially studying apoptosis regulation in normal and pathological immune cells, this had expanded to include wider fundamental and translational aspects in Immuno-Hematology, with focus on Chronic Lymphocytic Leukemia (CLL). In recent years, he shifted towards immunometabolism, with focus on the intrinsic metabolic changes in CLL as well as the impact of malignant cells on (CAR) T cell function and metabolism.

Franz Zemp

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada

fjzemp@ucalgary.ca

Biochemistry Molecular and cell biology

Dr. Zemp began his research training studying plant-pathogen interactions and epigenetics during undergraduate (BSc, ’06) and graduate (MSc, ’08) degrees at the University of Lethbridge. This was followed by doctoral training (PhD, ’15) at the University of Calgary where he studied neuroimmune responses to oncolytic virus treatment in brain cancer. He also completed two post-doctoral fellowships at the University of Calgary studying mucosal immunology and tumor immunology before being appointed as an Adjunct Assistant Professor in the Department of Biochemistry and Molecular Biology at the University of Calgary. Dr. Zemp is also the Lead of the Synthetic Immunology arm of the Alberta Cellular Therapy Immunology (ACTION) Program.

His research interests focus on three main themes: 1) Discovering novel immunotherapy targets for paediatric and AYA sarcomas; 2) Developing immunotherapies to target/co-target the tumour microenvironment; 2) Utilizing of oncolytic viral vectors as adjuvants for CAR T therapy.

Freek Ariese

LaserLaB, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands

f.ariese@vu.nl

Spectroscopy

Dr Ariese is Associate Professor, coordinator of the minor program Biomedical Imaging, and Deputy Director of LaserlaB Amsterdam, a European Large-scale Research Institute. Nowadays his main research activities are focused on Raman spectroscopy, with emphasis on advanced Raman modes. The results have been disseminated through almost 200 peer-reviewed publications. He teaches various spectroscopy courses at the bachelor, master and PhD level, and is involved in the management of a Europe-wide consortium of laser research centers. For several years he was also visiting scientist at the Indian Institute of Science in Bangalore, focusing on special applications of Raman spectroscopy. Current research activities are focused on advanced Raman spectroscopy for extra sensitivity, selectivity or speed. Applications can be (pre-)clinical, environmental, space, cultural heritage or material science. A deep-UV Raman setup was developed to improve plastic waste sorting in a recycling factory.

Gal Shafirstein

Department of Cell Stress Biology, Department of Head and Neck Surgery, Roswell Park Cancer Institute, Buffalo, NY, USA

Gal.Shafirstein@roswellpark.org

Oncology Photochemistry and photobiology Photodynamic therapy

Dr. Shafirstein is a Member/Professor of Oncology in the Department of Cell Stress Biology, and the Director of Photodynamic Therapy (PDT) Clinical Research at Roswell Park Cancer Institute. He is a materials scientist who is focused on the development of laser and thermal ablation devices and techniques for the treatment of cancerous tumors. Working in Roswell Park's PDT Center, Dr. Shafirstein's goal is to expand the use and enhance the translation of PDT. His research team invented and created real-time light dosimetry and treatment planning systems for PDT, which support three clinical studies at the PDT Center. He is also the co-leader of the clinical project of the PDT-PPG and serves as Director of the PDT Clinical Research Team, providing support for all light base diagnostic and treatment protocols at Roswell Park.

George G. Koliakos

Department of Biochemistry, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece

koliakos@yahoo.gr

Aging Rejuvenation mechanisms Stem cell differentiation Stem cell-extracellular matrix interactions

George Koliakos is a faculty member of the Medical School Aristotle University, currently serving as a full professor of Biochemistry (since 2012). He is President of the Hellenic Society for the Study of Regenerative Medicine. Dr. Koliakos has collaborated for the last 30 years with clinical departments of Aristotle University, including the departments of Internal medicine, in research considering metabolic syndrome, oxidative stress, atherosclerosis, and hypertension, Ophthalmology focused on the exfoliation syndrome, the most common cause of blindness of senior citizens and Surgery focused on wound healing. His current research interest includes stem cell differentiation, stem cell-extracellular matrix interactions, and aging and rejuvenation mechanisms. Dr. George Koliakos has co-authored 194 peer-reviewed papers in PubMed and Scopus with a total of 5635 citations and a current Hills Index of 39 (Google Scholar).

Giuseppe Esposito

Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, 00185 Rome, Italy

giuseppe.esposito@uniroma1.it

Colitis Gut microbiome Gut–brain axis Leaky gut Metabolic disorders Obesity

Giuseppe Esposito, Ph.D., is an associate professor of Pharmacology and Therapeutics at Sapienza University of Rome, Italy. His scientific focus is on the role of gliosis and neuroinflammatory processes in the central and enteric nervous systems. He is also involved in characterizing the role of gut microbiota-glia–neuron interplay during neuropathological disorders to provide more efficient pharmacological approaches to neurodegenerative diseases acting through the so-called gut-brain axis. Prof. Esposito is the author of almost 100 articles published in international peer review journals and is a member and co-founder of NEXTBIOMICS SRL. This spin-off operates in the field of microbiota engineering. Professor Esposito has been recently nominated as the President of the Scientific Committee of the Educational Society of Precision Medicine (SIEMPRE). Prof Esposito is a permanent member of the editorial board of international peer-reviewed pharmacology journals, such as Phytotherapy Research, and associate editor for Frontiers in Pharmacology (gastrointestinal session).

Guilermo Aguilar

Department of Mechanical Engineering, Texas A&M University, College Station, TX, USA

tamu-me-head@tamu.edu

Biophysics Engineering Mechanical engineering

Professor Guillermo Aguilar received his Bachelors degree in Mechanical and Electrical Engineering from the National Autonomous University of Mexico (UNAM) in 1993, and his Masters and Doctor of Philosophy degrees in Mechanical Engineering from the University of California, Santa Barbara in 1995 and 1999, respectively. His research interests focus on these themes: 1) Biological tissue thermal management/cryogenic spray cooling; 2) Biomedical optics/biomaterials development and characterization; 3) Non-invasive optical imaging; 4) Medical laser applications/laser-tissue rewarming; 5) Optical-induced cavitation/controlled surface erosion/mitigation

Hans Deckmyn

Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium

hans.deckmyn@kuleuven.be

Thrombosis and hemostasis

Dr. Hans Deckmyn, Department of Chemistry, KU Leuven, Belgium. One of the main research themes of the group of Prof. Deckmyn was the study of the interaction between platelet glycoprotein Ib and von Willebrand factor (VWF) that forms the bridge between collagen in the damaged vessel wall and platelets. Prof. Hans Deckmyn is (co)author of over 260 papers in international peer reviewed journals, 14 chapters in books and 4 patents.

Hardeep Singh Tuli

Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana 133207, India

hardeep.biotech@mmumullana.org

Biotechnology Cancer biology Cell culture Cell signaling Flow cytometry Gene expression

Dr. Hardeep Singh Tuli is a Associate Professor in Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana 133207, India (2015 - Present). He completed his PhD in Maharishi Markandeshwar (Deemed to be University), 2015. With broad research interests in Cancer Biology, Biotechnology, Cell Culture, Cell Signaling, Flow Cytometry, Gene Expression, Western Blot Analysis, Immunohistochemistry, Molecular Cell Biology, PCR. As a peer reviewer, he has helped many journals to review a lot of manuscript.

Jin Zhang

College of Biological, Chemical Sciences and Engineering, Jiaxing University, Jiaxing 314001, China

zhangjin7688@163.com

Metabolism and metabolic diseases Physiology Molecular and cell biology

Dr. Jin Zhang, obtained a PhD in Biochemistry and Molecular Biology from China Agricultural University in 2005. Visited the University of Colorado Health Medical Center in the United States and the University of Toronto Children's Hospital in Canada. In 2016, Dr. Zhang joined Jiaxing University and held positions such as the leader of the bioengineering discipline, member of the academic committee of the university, and vice president of the university. He has been committed to scientific research on the pathogenesis of metabolic diseases caused by obesity and the creation of related animal models. He used gene editing technology to construct four mouse models and three pig models, and identified multiple important genes and non coding RNAs that affect animal fat metabolism.

JingJing Zhang

State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing 210023, China

jing15209791@nju.edu.cn

Cancer therapy CRISPR technology Vitro diagnostics

Dr. Jingjing Zhang is a researcher at State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing 210023, China. He received a PhD degree in analytical chemistry from Nanjing University in 2010. His thesis project was to explore the use of functionalized carbon nanotubes in cytosensing and apoptosis diagnosis (in Jun-jie Zhu’s laboratory). After two years of postdoctoral research at Nanjing University, he moved to Prof. Yi Lu's group at the University of Illinois at Urbana-Champaign as a postdoctoral research associate, and got more interested in fundamental understanding of aptamers and their applications in medical diagnostics. Dr. Zhang started his own independent career in the School of Chemistry and Chemical Engineering at Nanjing University in 2019. He has broad research interests in CRISPR-based diagnostics of infectious diseases, aptamer-based biosensors, and new proteolysis-targeting chimeras. Dr. Zhang has published more than 60 SCI papers and authored two United States Patents, related to Chemistry, Materials, and Biology.

Jiongwei Wang

Department of Surgery, Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

jiongweiwang@gmail.com

Cardiology Drug delivery Hepatology

Dr. Jiong-Wei Wang is an Assistant Professor in July 2019 at the National University of Singapore. Besides Department of Surgery, he holds a joint appointment at the Department of Physiology for teaching. He is a Principal Investigator at the Cardiovascular Research Institute (CVRI; National University Heart Centre Singapore) and the Nanomedicine Translational Research Program (Yong Loo Lin School of Medicine). His research has been supported by National Medical Research Council (NMRC), Ministry of Education (MOE) and NUS/NUHS among others. He was awarded three times the “Young Investigator Award” by the International Society on Thrombosis and Haemostasis (ISTH), twice travel awards by the European Society of Cardiology (ESC), the Outstanding Mentor Award in 2019 by Wong Hock Boon Society–Singapore Medical Association (SMA) Charity Fund (WHBS-SMACF), and the Young Researcher of the Year Award for 2023.

Joaquim Carreras

Department of Pathology, Faculty of Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Japan

joaquim.carreras@tokai-u.jp

Hematopathology Histopathology Immune microenvironment Immuno-oncology Molecular pathology

Dr. Joaquim Carreras is a pathologist with a medical degree from the University of Barcelona, Spain. He is a specialist of Pathology at the Hospital Clinic of Barcelona, Spanish Ministry of Health. His obtained his PhD in hematopathology from the Department of Pathology, Faculty of Medicine, University of Barcelona. He has worked as pathologist in Spain, as a medical research associate at the University of Cambridge (UK), AIST Tsukuba central (Biomedical Research Institute), and currently works at Tokai University School of Medicine, Japan

Joshua A. Jackman

Chemical Engineering and Translational Nanobioscience Research Center, Sungkyunkwan University, South Korea

jjackman@skku.edu

Biophysics Biosensors Interfacial science

Prof. Joshua A. Jackman is an assistant professor in the School of chemical engineering and biomedical institute for convergence at Sungkyunkwan University (SKKU) in South Korea. He is also the director of the translational nanobioscience research center at SKKU.  

Khalid Siddiqui

Strategic Center for Diabetes Research, College of Medicine, King Saud University, Riyadh, Saudi Arabia

Associate professor at College of Medicine, King Saud University, Riyadh, Saudi Arabia

Researcher at Center for Diabetes Research, College of Medicine, King Saud University, Riyadh, Saudi Arabia

khalid01@gmail.com

Metabolism and metabolic diseases Nephrology Physiology

Dr. Khalid Siddiqui is an Associate Professor in the College of Medicine and Researcher at the Strategic Center for Diabetes Research (SCDR), King Saud University Riyadh Saudi Arabia. After doing postdoctoral training at The University of Manchester he joined the King Saud University faculty in 2008. His research focuses on diabetes mellitus, a condition which currently affects more than 450 million of the adult population worldwide and whose incidence is expected to increase further in the coming years. In the Arab world, the situation is more alarming as more than 30% people have different types of diabetes.  His main goals are to develop new means to understand the high prevalence/ incidence of diabetes and different complications of Diabetes like Diabetes Kidney disease (DKD)/ Diabetic nephropathy.

Khawaja Husnain Haider

Department of Basic Sciences, Sulaiman AlRajhi University, Saudi Arabia

kh.haider@sr.edu.sa

Genetics and gene therapy Stem cells

Prof. Khawaja Husnain Haider is currently working as a full professor and chairman of Basic Sciences in Sulaiman AlRajhi University (Medical Program), Saudi Arabia. 

Prof. Haider has published 4 books, more than 275 research papers, book chapters, and conference abstracts. His current interest, based on his extensive research experience in stem cells and gene therapy, either alone or as a combined approach, is to use stem cells and DNA as drugs in regenerative medicine

Kota V. Ramana

Department of Biomedical Sciences, Noorda College of Osteopathic Medicine, Provo, UT 84606, USA

karamana@noordacom.org

Carcinogenesis Inflammatory complications Oxidative stress-induced signal transduction mechanisms Pathophysiology of secondary diabetic complications

Dr. Kota Ramana is a Professor at Department of Biomedical Sciences, Noorda College of Osteopathic Medicine, Provo, UT-USA. He is also an adjunct professor at Roseman University of Health Sciences. He received Ph.D. in Biochemistry from Postgraduate Institute of Medical Education and Research, India.  The chief objectives of his lab investigations are to examine the involvement of cellular metabolism and oxidative stress signals in inflammation.  His lab uses various genetic, biochemical and cell biological approaches to analyze inflammatory responses regulated by cellular lipid metabolites leading to secondary diabetic complications and cancer. He has published more than 130 peer reviewed articles, and 12 book chapters.

 

Luis Martinez-Sobrido

Texas Biomedical Research Institute, San Antonio, TX 78245, United States

LMartinez@txbiomed.org

Immunology Virology Vaccines Virus-host interactions

Dr. Martinez-Sobrido is a Professor at the Texas Biomedical Research Institute, Adjunct Professor in the Department of Microbiology, Immunology and Molecular Genetics (MIMG) at the University of Texas Health Science Center San Antonio (UT-Health SA), and Adjunct Professor at the Department of Microbiology at University of Texas San Antonio (USTA). His Ph.D. research focused on the study of viral replication and transcription of respiratory syncytial virus under the guidance of Dr. Jose Antonio Melero at the Instituto de Salud Carlos III in Madrid, Spain. He conducted post-doctoral research on the molecular biology of influenza viruses under the supervision of Dr. Adolfo Garcia-Sastre at the Icahn School of Medicine at Mount Sinai in New York, USA. Dr. Martinez-Sobrido’s research interest during the last 20 years have been focused on the molecular biology, immunology and pathogenesis of negative-stranded and positive-stranded RNA and DNA viruses. His current research interest focuses on the molecular biology of RNA viruses. Dr. Martinez-Sobrido has extensive knowledge in plasmid-based reverse genetics techniques to rescue recombinant viruses, pioneered the development of techniques and screening assays to identify and characterize viral-encoded interferon antagonist proteins, established new molecular biology techniques to study highly pathogenic viruses without the requirement of special biosafety conditions. His expertise also includes antiviral and vaccine development and establishment of animal models of viral infections.

Maarten Bijlsma

Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands

m.f.bijlsma@amsterdamumc.nl

Oncology Molecular and cell biology

After his postdoctoral research at other institutes including the University of California at Berkeley, Dr. Maarten Bijlsma, returned to the Academic Medical Center as a junior group leader, and is currently assistant professor. His research focuses on pancreatic and esophageal cancer, from the most fundamental mechanisms that underlie aberrant signaling in these diseases, to the development of serum-borne markers in patient cohorts to predict treatment response and disease outcome. Furthermore, he was Biomarker/Imaging Program leader for the Amsterdam UMC Cancer Center Amsterdam during the first 3 years of its existence.

Makoto Noda

Graduate School of Medicine, Faculty of Medicine in Kyoto University, Kyoto, Japan

noda.makoto.72z@st.kyoto-u.ac.jp

Extracellular matrix Molecular oncology Neural development Tumor angiogenesis

Prof. Makoto Noda studied organic chemistry, microbial genetics, and molecular biology at Keio University and Tokyo Institute of Technology, Japan. His PhD study was to clone a primate retroviral (baboon endogenous virus) genome into bacteriophage and to use its fragments to isolate retrovirus-related sequences in the human genome, elements still hypothetical at that time. His postdoctoral study at National Cancer Institute, USA, led to the first demonstration of functional diversity among oncogenes. His subsequent studies (at Keio University, RIKEN, Japanese Foundation for Cancer Research, and Kyoto University) include the discovery of a paradoxical activity of RAS to induce neuronal differentiation in PC12 cells, isolation of Rap1 and RECK as transformation suppressor genes, isolation of a series of genes whose expression is abundant in mouse neural precursor cells but low in mature brain (termed Nedd genes), elucidation of physiological functions of some of these genes using cell culture and mouse genetics, and development of functional assays useful for screening potential anti-cancer/metastatic drugs.

Marcello Iriti

Department of Biomedical, Surgical and Dental Sciences, UniversitĂ  degli Studi di Milano, 20133 Milan, Italy

marcello.iriti@unimi.it

Nutrition Antimicrobial resistance Bioactive phytochemicals Essential oils Ethnopharmacology One health

Marcello Iriti is a professor of Pharmaceutical Biology at the Department of Biomedical, Surgical and Dental Sciences, Milan State University. He has been studying nutraceuticals, functional foods, phytotherapeutics, and essential oils relevant to human and animal health, focusing on their preclinical (in vitro/in vivo) and in human pharmacological activities. He has been investigating the health-promoting effects of the traditional Mediterranean diet and the ethnopharmacology of herbal remedies of traditional healing systems.

Marco Fiore

Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Unit of Translational Biomolecular Medicine, Department of Sense Organs (DOS), Sapienza University of Rome, Viale del Policlinico 155, 00161 Roma, Italy

marco.fiore@cnr.it

Addiction Neurobiology Oxidative stress Toxicology

Dr. Marco Fiore is a researcher at the Institute of Biochemistry and Cell Biology of the Italian National Research Council, IBBC-CNR in Rome, Italy. He studied Natural Sciences and Biological Sciences at the Sapienza University of Rome, Italy. He got his Ph.D. in Medical Sciences at the Psychiatric Department of the University of Groningen, The Netherlands. In addition, he potentiated his professional experience also at the Institute of Zoology, Oxford University, UK, and at the Department of Physiology and Behavior, University of California at Davis, CA-USA. With broad research interests in oxidative stress, neurobiology, toxicology, addiction.

Marco Zaffanello

Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona - Piazzale Stefani, 1, 37134-I Verona, Italy

marco.zaffanello@univr.it

child health Nephrology pediatric nephrology Obesity physical activity sleep medicine Urinary tract infections

Marco Zaffanello, MD, is an Associate Professor of Pediatrics in the Department of Surgery, Dentistry, Pediatrics, and Gynecology at the University of Verona, Italy. He graduated with a degree in Biological Sciences in 1989 and a degree in Medicine and Surgery in 1997. He specialized in Pediatrics in 2001. Throughout his scientific career, he has been involved in research on inherited metabolic diseases and pediatric nephrology. His leading research focuses on sleep-disordered breathing and sleep apnea syndrome in children. With broad research interests in Pediatric Nephrology, Obesity, Physical Activity, Child Health, Urinary Tract Infections, Nephrology, Sleep Medicine, Sleep Apnea. he has published many full articles and reviews in peer-reviewed journals. He has collaborated with various research groups, including Bambino Gesù Children's Hospital (Rome, Italy), University of Catania (Catania, Italy), Mayo Clinic and Foundation in Rochester (Minnesota, USA), UZ Leuven University Hospital (Belgium), University of Leuven and Flanders (Belgium), University of Cagliari (Italy), Kapodistrian University (Athens, Greece), Department of Pathology at KU Leuven (Belgium), University of California (USA), Università dell'Insubria (Italy), National Research Council (Palermo, Italy) and Carlo Poma Hospital (Mantua, Italy). He has also served as a speaker at national and international conferences. He has been a lecturer at the University of Verona for the Nursing Science degree program and the Obstetrics and Pediatric specialization programs.

Marco G. Alves

Principal Investigator at Institute of Biomedicine - iBiMED and Department of Medical Sciences, University of Aveiro, 3810-193, Aveiro, Portugal

maalves@icbas.up.pt

Andrology Metabolism Metabolomics Mitochondria Spermatogenesis

Marco G. Alves obtained his PhD in Biochemistry, specializing in bioenergetics, from the University of Coimbra (Portugal) in 2011. Leading a dedicated research group in Endocrinology, Metabolism, and Male Reproduction, he focuses on various aspects of male reproductive biology, metabolic modulation, obesity, and the physio-pathological factors influencing subfertility or infertility. Dr. Alves is particularly engaged in investigating metabolic cooperation in spermatogenesis, metabolic-related infertility—especially linked to diabetes and obesity—and the underlying mechanisms driving these phenomena. Since 2015, he has been actively supervising numerous PhD students and post-doctoral researchers. His outstanding research contributions have earned him multiple national and international prizes and grants, including prestigious competitive international funds.

Martin Hagedorn

Bordeaux University, Bordeaux, France

martin.hagedorn@u-bordeaux.fr

Oncology Biology Molecular and cell biology

Dr Martin Hagedorn is a biomedical expert in Biology & Biochemistry and Molecular Biology & Genetics. Since September 2014, Dr Martin Hagedorn has been leading a team of researchers (Caroline CAPDEVIELLE, Farah RAHAL, Justine CHARPENTIER and Mélissa MENARD) which devotes its research work to the identification of new therapeutic targets in brainstem tumors and to the improvement of its treatment methods. Work recognized by several European scientific teams & experts. In addition, the project led by Farah Rahal under the leadership of Dr Martin Hagedorn aims to improve the treatment of children with brainstem tumors.

Martin Hermann

Department of Anesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria

martin.hermann@tirol-kliniken.at

Anesthesiology Biology

Dr. Martin Hermann was working with Department of Anesthesiology and Critical Care Medicine, at Innsbruck Medical University, Innsbruck, Austria. His research interests focus on Anatomy, Endocrinology and Anesthesiology.

Matteo Cerri

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy

matteo.cerri@unibo.it

Neurosciences Physiology Neuroethics

Dr. Matteo Cerri is an Associate Professor of Physiology (M.D., Ph.D.) at the Department of Biomedical and NeuroMotor Sciences of the University of Bologna, Italy. His research focuses on hibernation and on methods to induce a state resembling hibernation in non-hibernators, including humans. Currently consulting for the European Space Agency and for the Italian Space Agency. Member of the National Institute for Nuclear Physics. Member of the Italian Institute of Technology.

Matthias Ocker

Medical Department, Division of Hematology, Oncology and Cancer Immunology, Campus Charité Mitte, Charité University Medicine Berlin, Berlin, Germany

Head of Translational Medicine, Tacalyx GmbH, Berlin, Germany

matthias.ocker@charite.de

Cell physiology Gastroenterology Hemato-oncology

Dr. Matthias Ocker, is a faculty member and adjunct professor of experimental medicine at Charité University Medicine Berlin, Germany. Dr. Matthias brings more than 20 years of academic and industry experience in oncology and GI diseases at Bayer and at Boehringer Ingelheim. He held global senior positions in early drug development with a strong focus on biomarkers, translational medicine and clinical pharmacology. Matthias has led several programs into Phase 1 and to proof of concept and was a member of global portfolio steering committees. He has authored more than 130 scientific publications and book chapters and is a member of several academic societies like AACR and EASL.

Maurice van den Hoff

Department of Medical Biology, Section Clinical Anatomy & Embryology, Amsterdam Reproduction & Development Research institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands

m.j.vandenhoff@amsterdamumc.nl

Cardiovascular physiology Embryology and development

Dr. Maurice van den Hoff currently works at the Department of Medical Biology, Amsterdam University Medical Centers, location Academisch Medisch Centrum, Universiteit van Amsterdam. Maurice does research in Cell Biology, Developmental Biology and Molecular Biology. Their current projects are '3D human embryology', 'quantitative PCR' and 'role of Follistatin-like 1 in development and disease'.

Michael Hamblin

Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, South Africa

hamblin.lab@gmail.com

Dermatology Photochemistry and photobiology Photodynamic therapy

Prof. M.R. Hamblin (Ph.D.) was the Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School and is a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology. His research interests lie in the areas of photodynamic therapy (PDT) for infections, cancer, and heart disease and photobiomodulation for wound healing, arthritis, traumatic brain injury and hair regrowth. He has published over 600 peer-reviewed articles, over 150 conference proceedings, book chapters and international abstracts and holds 8 patents. He is Associate Editor for 10 journals, on the editorial board of a further 25 journals and serves on NIH Study Sections.

Michael Retsky

Harvard TH Chan School of Public Health, Boston, MA 02115, USA

michael.retsky@gmail.com

Biophysics Breast cancer Cancer Computational biophysics Computational physics Metastasis Tumors

Dr. Michael Retsky made a career change to cancer research thirty years ago. He is on staff at Harvard TH Chan School of Public Health and Angiogenesis Foundation, both in Boston. He is also on faculty at University College London. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. He received a PhD in experimental physics from University of Chicago in 1974. His thesis project was to build a scanning transmission electron microscope that could resolve single atoms of silver, mercury and uranium and measure their elastic cross-sections (in Albert Crewe’s laboratory). While doing electron optics research at Hewlett-Packard in 1982, a friend’s wife was diagnosed with cancer. This friend organized an informal research group to study cancer and possibly help his wife. He got more interested in cancer research than physics research and gradually made a career change over a period of 5 years. He read every paper he could find at Penrose Cancer Hospital. With broad research interests in Medical ans surgical emergencies in Computational Biophysics, Metastasis, Tumors, Computational Physics, Biophysics, Cancer, Breast Cancer Screening, Colon Cancer. He is a founder and on the Board of Directors of the Colon Cancer Alliance and has published more than 60 papers in physics and cancer.

Nicanor Moldovan

Department of Ophthalmology, Indiana University School of Medicine and Indiana University-Purdue University at Indianapolis, Indianapolis, IN, USA

nimoldov@iupui.edu

Experimental medicine

Dr. Moldovan is Associate Research Professor at IUPUI, and founding Director of the 3D Bioprinting Core at Indiana University School of Medicine. After a post-doctoral training in Cardiovascular Medicine at Johns Hopkins University, he performed extensive Biomedical Engineering research at the Oho State University in Columbus, OH. Among other NIH and AHA funding, he received an RC2 ARRA ‘stimulus’ grant on the interaction of circulating vascular progenitor cells with polymeric micro-fibrils. Dr. Moldovan is the founding Director of the 3D Bioprinting Core at IUSM/IUPUI, equipped with the state-of-the-art 'Regenova' bioprinter, and with the automatic fluorescence microscope 'IncuCyte ZOOM'. To cover the bioprinter's cost, he won a large NIH S10/Shared Instrument Grant award, on which he is Principal Investigator. He is also an Associate Editor of Journal of Cellular and Molecular Medicine.

Nienke Vrisekoop

Center for Translational Immunology, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands

N.Vrisekoop@umcutrecht.nl

Immunology Molecular and cell biology

Dr. Nienke Vrisekoop is Associate Professor at the Center of Translational Immunology at the UMCU. Nienke Vrisekoop’s core research interest is immune cell dynamics in health and disease. In 2013 she started as an Assistant Professor at the Department of Respiratory Medicine in the Center of Translational Immunology of the UMCU where she studies neutrophils that are the first responders of the immune system. These immune cells can recognize and engulf both micro-organisms and foreign matter such as microplastics that penetrate the body. She now focuses in her laboratory on the mechanisms that neutrophil employ to deal with these threats.

Oscar Campuzano

Cardiovascular Genetics Center, University of Girona-IDIBGI, 17190 Girona, Spain

oscar.campuzano@udg.edu

Cardiomyopathies Genetics Inherited arrhythmias Molecular autopsy Sudden cardiac death

Dr. Oscar Campuzano graduated in Biology (Biosciences) from the University of Barcelona (Spain) in 2002. He obtained his PhD from the Autonomous University of Barcelona (Spain) in 2008. Later, he joined as a postdoctoral fellow at the Cardiovascular Genetics Center of the University of Montreal (Canada). In 2010 he returned to Spain where he obtained a senior researcher position at the Center for Cardiovascular Genetics and a professorship at the Faculty of Medicine (University of Girona). Dr. Campuzano has published more than 150 peer-reviewed articles and several book chapters. He has also been principal investigator of more than 10 projects. Currently, Dr. Campuzano is dedicated to basic and clinical research on pathologies associated with Sudden Cardiac Death, allowing the results of basic research to be transferred to clinical practice.

Panagiotis J. Vlachostergios

Department of Medicine, Division of Hematology and Medical Oncology, Weill Medical College of Cornell University, New York, NY, USA

pjv9003@med.cornell.edu

Apoptosis Cancer biology Cell culture Cell signaling Public health

Dr. Panagiotis J. Vlachostergios is an Assistant Professor in the Department of Medicine, Division of Hematology and Medical Oncology, Weill Medical College of Cornell University, New York, NY, USA. He received his Ph.D. in Cancer Biology in 2013. He completed his Internal Medicine Residency at New York University School of Medicine, Langone Hospital and his Hematology and Medical Oncology Clinical Fellowship at Weill Cornell Medical College, New York Presbyterian Hospital. He has further completed post-doctoral training in Genomic Cancer Risk Assessment (City of Hope Comprehensive Cancer Center); Genetics and Genomics (Stanford University); Genetics, Cancer Genomics and Precision Oncology (Harvard Medical School); Immunology and Immuno-Oncology (Harvard Medical School); and Clinical Research (Weill Cornell Clinical and Translational Science Center). With broad research interests in Medical ans surgical emergencies in Cell Culture, Cell Signaling, Cancer Biology, Apoptosis, Public Health, Article Writing, PCR, Immunohistochemistry, Flow Cytometry, Gene Expression. He has published more than 100 international peer-reviewed articles, and authored several book chapters and abstracts. His research has been highly cited and he is a recipient of prestigious awards from the American Society of Clinical Oncology, European Society of Medical Oncology, Society for Translational Oncology, American Federation for Medical Research, Bladder Cancer Advocacy Network, and others. He serves as an investigator on CDMRP-funded and industry-sponsored clinical studies.

Paul R. Cooper

Faculty of Dentistry, Sir John Walsh Research Institute, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand

p.cooper@otago.ac.nz

Dental phototherapy Dental tissue engineering Host-pathogen Interactions in dental disease Pulp biology

Paul currently conducts research into dental tissue regeneration, the inflammatory/immune aspects of oral and dental disease and in the biomaterials area with focus in pulp biology. In 2010, he received the Young Investigator Award from the International Association for Dental Research (IADR). He has served as Chair of the Mineralised Tissue Group (MINTIG), councillor for the British Society for Oral and Dental Research (BSODR). He has been the President of the Pulp Biology and Regeneration Group (PBRG) of IADR, and is the incoming President of IADR-ANZ. Paul has been the Deputy Head of School of Dentistry at the University of Birmingham, UK, and is currently (July 2022) the Dean of the Faculty of Dentistry, University of Otago, NZ. He serves on the Editorial Board of several dental journals.

 

Peichen Pan

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China

panpeichen@zju.edu.cn

Cancer biology Glioma Molecular docking Molecular dynamics Molecular modeling Virtual screening

Dr. Peichen Pan is, since 2021, a Distinguished Research Professor at the Innovation Institute for Artificial Intelligence in Medicine at Zhejiang University's College of Pharmaceutical Sciences, located in Hangzhou, Zhejiang, China. He obtained his Doctor of Philosophy (Ph.D.) in Medicinal Chemistry from Zhejiang University's College of Pharmaceutical Sciences, China, between 2014 and 2019. Previously, he held the position of Research Fellow at the Department of Cancer Biology in Harvard Medical School and the Dana-Farber Cancer Institute in the United States from 2019 to 2021.

Dr. Pan's primary interests involve the development and application of state-of-the-art computational and theoretical techniques. His research focuses on investigating the structures, functions, and dynamics of important drug targets. He also employs computational approaches and chemical/biological experiments to design potential new drugs. He has published over 50 articles in peer-reviewed journals including Nature Communications, Science Advances, ACS Central Science, Chemical Science, Journal of Medicinal Chemistry, Research, Drug Discovery Today, Antiviral Research, and Journal of Chemical Information and Modeling.

Peter MakovickĂ˝

Department of Histology and Embryology, Faculty of Medicine, University of Ostrava, Czech Republic

pmakovicky@email.cz

Pathology Histology Veterinary histology

Dr. Peter Makovický graduated from the Slovak University of Economics in Nitra. In 2005-2008 he worked at the Institute of Pathology FN in Nitra. Since 2008 he has been a professional assistant of the Department of Veterinary Disciplines at the Czech University of Agriculture in Prague.

Pingping Zhu

School of life sciences, Zhengzhou University, Zhengzhou, China

zhup@zzu.edu.cn

Colorectal cancer CRISPR/Cas9 screening Image based screening Liver cancer Stem cells Wnt/β-Catenin Signaling

Prof. Dr. Zhu Pingping has been engaged in research on the regulatory mechanism of stem cells, including Adult Stem Cells (ASCs) in physiological conditions at Zhengzhou University.Since his PhD, Zhu Pingping has been engaged in research on the regulatory mechanism of stem cells, including Adult Stem Cells (ASCs) in physiological conditions (such as intestinal stem cells, ISCs) and Cancer Stem Cells (CSCs) in pathological conditions (such as intestinal CSCs and liver CSCs). The regulatory mechanisms include epigenetic regulation (such as non-coding RNAs, chromatin remodeling complexes, DNA modifications), transcriptional regulation, and microenvironmental regulation.

Piter Bosma

Department of Gastroenterology & Hepatology and Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology & Metabolism, Amsterdam University Medical Centers, Amsterdam, the Netherlands

p.j.bosma@amsterdamumc.nl

Genetics and gene therapy Hepatology

Dr. Piter Bosma, is an Associate Professor, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism. His main focus is to develop Adeno Associated liver directed gene therapy to treat inherited unconjugated hyperbilirubinemia. This research is funded by the Dutch Najjar foundation and by ZonMw. In collaboration with the group of Prof.Dr Labrunne and the AFM they plan to start a phase 1 trial end 2016 or start 2017. Succesfull application of AAV in this patients will also enable them to use this strategy to treat other inherited liver diseases such as PFIC.

Rainer Böger

Institute of Clinical Pharmacology and Toxicology University Medical Center Hamburg-Eppendorf, Hamburg, Germany

boeger@uke.de

Cardiovascular diseases Chronic lung diseases Diabetes Inflammation

Prof. Dr. Böger has specialized in Clinical Pharmacology, Pharmacology and Toxicology. He is the director of the Institute of Clinical Pharmacology and Toxicology at the University Medical Center Hamburg-Eppendorf. His major research interest is focused on translational research to better understand mechanisms of chronic human diseases, with efforts to develop novel approaches for prevention and therapy; these comprise studies in cardiovascular disease, diabetes, chronic lung diseases, and inflammation. His activities span molecular and biochemical studies, genetically modified animal models, and human proof-of-concept studies. Developing biomarkers to better discriminate between high- and low-risk individuals is a core activity of his team.

Roberto Gramignoli

Dept. of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Sweden

roberto.gramignoli@ki.se

Regenerative medicine Liver regeneration

Dr. Roberto Gramignoli, Karolinska Institutet, Stockholm, Sweden. His primary interest has always been to optimise cell-based therapies to treat fulminant liver failure or congenital defects. Hepatocyte transplantation has been gaining recognition as a bridge, or an alternative, to liver transplantation. His group optimised methods to isolate human hepatocytes, to cryopreserve and to evaluate hepatic functions before transplant. Due to the paucity of human hepatocytes, they also investigated alternative sources: they evaluated fetal liver cells, and hepatocytes from newborn and pediatric patients. They proved efficacy of inborn error hepatocytes as alternative cell source for clinical and identified in placental amnion epithelial cells an efficient alternative allogenic source of cells to transplant without immunosuppression.

Ronald Wilders

Department of Medical Biology, Section Clinical Anatomy & Embryology, Amsterdam Reproduction & Development Research institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands

r.wilders@amsterdamumc.nl

Cardiovascular physiology

Dr. Ronald Wilders, department of Medical Biology, Amsterdam UMC, University of Amsterdam. His research interests focus on Cardiac Cellular Electrophysiology, Biomathematical and Biophysical Modeling and Arrhythmias. Cardiac impulse formation and propagation under normal and abnormal conditions.

Salvatore Passarella

School of Medicine University "Aldo Moro", Piazza Giulio Cesare, 70121 Bari, Italy

spassarella3@gmail.com

Energy metabolism Light-biological systems interactions Mitochondrial transport Programmed cell death

Salvatore Passarella, Chemistry graduate in 1970, and assistant from 1971 to 1983, and later associate professor in Cell Biochemistry from 1983 to 1990 at the University of Bari, and finally from 1990 to 2015 was full professor of Biochemistry at the University of Molise, where he also served as the Dean of the Agriculture Faculty from 1993-1996 and pro-rector between 1995 and 2013

He taught Enzymology, Cell Biochemistry and Biochemistry in the Universities of Bari, Foggia, of Basilicata and Molise and published 6 books on these subjects.

He has published over 160 papers. His research interests are in animal, plant and yeast mitochondria under physio-pathological conditions. In particular in: Mitochondrial transport in energy metabolism of a variety of metabolites including D-L lactate, fumarate, oxaloacetate, glutamine, ornithine, proline hydroxyproline etc

The discov.ery of new mitochondrial enzymes: D- and L-lactate dehydrogenase, L-lactate oxidase and pyruvate kinase; transport of proteins in isolated mitochondria; transport of vitamins and vitamin derivatives in isolated mitochondria; the role of animal, plant and yeast mitochondria in apoptosis; and effect of laser light on mitochondria bioenergetics and on biological system biochemistry.

Sathish Thirunavukkarasu

Department of Family and Preventive Medicine at Emory University School of Medicine in Atlanta, USA

speaktosat@gmail.com

Implementation science Lifestyle interventions Prediabetes Prevention Primary care Type 2 diabetes

Sathish Thirunavukkarasu is an Assistant Professor in the Department of Family and Preventive Medicine at Emory University School of Medicine in Atlanta, USA. Sathish completed his Medical Degree, a Diploma in Family Medicine, and a Master's Degree in Public Health in India. He also earned a PhD in Epidemiology from the University of Melbourne in Australia. Following his PhD, he pursued two years of post-doctoral training at Nanyang Technological University in Singapore and another three years at McMaster University in Canada. His primary research interests center around "precision prevention of type 2 diabetes" through lifestyle and pharmacological interventions. Sathish has published over 114 scientific papers, some of which have appeared in high-impact factor journals such as Nature Reviews Endocrinology, The Lancet Diabetes & Endocrinology, The Lancet Global Health, Annual Review of Public Health, Diabetes Care, and PLoS Medicine, often as the lead author.

Sebastian A. J. Zaat

Department of Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands

s.a.zaat@amsterdamumc.nl

Microbiology

Dr. Zaat’s research line "Biomaterial-associated infection and novel antimicrobial strategies”, is focused on pathogenesis, prevention and treatment of biomaterial-associated infections, both in soft tissue (catheters, surgical meshes) and bone (implants, fixation devices). Since 2010 he is Principal Investigator and has extensive experience in the field of Biomaterials and Infection research, including research on antimicrobial peptides as alternatives for antibiotics. He was involved in or coordinated the BMM NANTICO “Non-adherent ANTImicrobial Coatings” project, BMM IBIZA “Imaging of Biomaterial-associated Infection using Zebrafish Analysis”, EU FP7 BALI “Biofilm Alliance” project developing novel Synthetic Antimicrobial and Antibiofilm Peptides, and the EU COST Consortium IPROMEDAI “Improved PROtection Of Medical Devices Against Infection” and Dutch National consortia Craniosafe, SuperActive and PHOTO-TREAT.

Sylvestre Bonnet

Leiden Institute of Chemistry, University of Leiden, Leiden

bonnet@chem.leidenuniv.nl

Photochemistry and photobiology

Dr. Sylvestre Bonnet is Full Professor in Bioinorganic Chemistry at Leiden University. Between 2009 and 2014 he completed a Tenure Track position in Inorganic Chemistry at Leiden University, where he was tenured in 2015 and became full professor in 2020. He obtained several prestigious grants, including a Starting Grant from the European Research Council (2013), a Transition grant from the European Innovation Council (2023), and three young investigator grants (VENI 2008, VIDI 2012, VICI 2019) from the Dutch Organisation for Scientific Research (NWO). Dr. Sylvestre Bonnet studies the (photo)chemistry of metal-based molecules in biological and biomimetic environment. By combining bioinorganic chemistry and photochemistry his group makes new light-activatable prodrugs for use as targeted anticancer agents with minimal side effects. Another part of the group studies how to assemble metal-based photosensitizers and catalysts to trap the sun energy into a solar fuel.

Terry Lichtor

Department of Neurological Surgery, Rush University Medical Center, Chicago, IL, USA

Terry_Lichtor@rush.edu

Brain physiology Brain tumors Glioma Medical neurosciences Neurobiology Spine surgery Thyroid

Dr. Terry Lichtor is Clinical Professor of Department of Neurological Surgery, Rush University Medical Center, Chicago, IL, USA. 1981-1982 Internship in General Surgery, Mayo Graduate School of Medicine, Rochester, Minnesota 1981-1987 Residency in Neurological Surgery, The University of Chicago, Chicago, Illinois Research Fellowships: 1987-1989 Research Fellow, Committee on Neurobiology, The University of Chicago, Chicago, Illinois 1989-1990 Research Associate, Department of Cell, Molecular and Structural Biology, Northwestern University, Chicago, Illinois Terry Lichtor, MD, PhD 2 Licensure: 1982 State of Illinois 2008 State of Arkansas 2009 State of Wisconsin 2011 State of South Dakota Board Certification: 1982 National Board of Medical Examiners 1991 American Board of Neurological Surgery Academic Appointments: 1990-1991 Research Assistant Professor, Department of Cell, Molecular and Structural Biology, Northwestern University Medical School, Chicago, Illinois 1991-1992 Assistant Professor, Department of Surgery, Harvard Medical School, Boston, Massachusetts 1996-2003 Assistant Professor, Department of Neurological Surgery, Rush University, Chicago, Illinois 1996- Clinical Associate Professor, Department of Neurological Surgery, Loyola University Chicago, Chicago, Illinois 2003- Associate Professor, Department of Neurological Surgery, Rush University, Chicago, Illinois 2014- Clinical Professor, Department of Surgery, New York Institute of Technology/Arkansas State University Hospital Appointments: 1987-1991 Attending Neurosurgeon, Little Company of Mary Hospital, Evergreen Park, Illinois 1991-1992 Attending Neurosurgeon, Beth Israel Hospital, Boston, Massachusetts 1992-2007 Attending Neurosurgeon, John H Stroger Hospital of Cook County, Chicago, Illinois 1996-2004 Attending Neurosurgeon, Edward Hines Hospital. With broad research interests in Medical ans surgical emergencies in Medical Neurosciences, Neurobiology and Brain Physiology, Brain Tumors, Spine Surgery, Thyroid, Glioma. He is a member of the neurosurgery department at Rush University Medical Center.

Tiancai Liu

Professor, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China

Member of Guangdong Immunology Society, China

liutc@smu.edu.cn

Diagnostics Antibody Laboratory medicine

Dr. Liu is the Deputy Director of the Antibody Engineering Institute of Southern Medical University, a postdoctoral fellow of the National University of Singapore, imported talents of Southern Medical University. Dr. Liu is skilled at new in vitro diagnostic technology research and kit development. Research interests are biology and laboratory medicine.  Focuses are on genetic disease metabolism of small molecules, proteins, and nucleic acid mass spectrometry research.

Main academic achievements are National "863" science and technology program project, National Natural Science Foundation (Youth and general program), doctoral Foundation of higher education institutions, Guangdong Provincial higher Education Talent Introduction Project, Guangdong Provincial Natural Science Foundation; We also participate in national major science and technology projects, sub-projects of National major science and technology projects and National Natural Science Foundation projects. three national invention patents were applied for and one was granted

Ton Lisman

Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands

j.a.lisman@umcg.nl

Hepatology Thrombosis and hemostasis

Dr. Ton Lisman, Full Professor of Experimental Surgery, Surgical Research Laboratory, Department of Surgery, University Medical Center Groningen, The Netherlands. He is one of the few experts worldwide on clinical and fundamental research on bleeding and thrombosis in patients with liver diseases. In the past decade, through a combination of careful analysis of the clinical phenotype of these patients and in-depth laboratory analyses, his group has been able to redefine the clinical consequences of hemostatic changes associated with liver diseases. In particular, they demonstrated that patients with chronic and acute liver diseases are in a hemostatic ‘rebalance’ due to a concomitant decline in pro- and antihemostatic forces. These novel insights have had profound consequences for clinical management, and have led to worldwide changes in the approach to treatment and prevention of bleeding in patients with liver diseases.

Vikrant Rai

Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA

vrai@westernu.edu

Immunology Oncology Molecular and cell biology

Vikrant Rai is an Assistant Professor in the Department of Translational Research at the Western University of Health Sciences, Pomona, CA. His research interests are investigating inflammatory molecular pathologies underlying various chronic inflammatory diseases and delineating immunomodulation and immunotherapeutic strategies. Prof. Rai has published more than 50 peer-reviewed articles, and 11 book chapters, and have edited 2 books. 

Wonkyu "Daniel" Ju

Hamilton Glaucoma Center and Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA 92093, USA

wju@health.ucsd.edu

Alzheimer’s disease Glaucoma Glial cells Mitochondrial dysfunction Mitochondrial protection Neuroinflammation Oxidative stress Retinal ganglion cell

Wonkyu Ju, Ph.D., is a Professor of the Viterbi Family Department of Ophthalmology specializing in Glaucoma at the University of California, San Diego, USA. Dr. Ju received his M.S. and Ph.D. in the Department of Anatomy at the Medical College of Catholic University in Korea and then completed a post-doctoral position in the Department of Ophthalmology and Visual Sciences at Washington University in St. Louis, USA, studying the cellular and molecular mechanisms of cell death and protection in retinal ischemia and glaucoma. Dr. Ju’s current research focuses on the fundamental issues of mitochondria network and function in neurodegeneration, neuroinflammation, and neuroprotection in glaucoma and Alzheimer’s disease. He has an extensive publication record, with over 60 scientific papers and book chapters, and has received support from the National Institute of Health (NIH) in Maryland, USA. He has also contributed as a reviewer for numerous scientific journals and has held a standing member position at NIH, USA

Xiong Ma

Division of Gastroenterology and Hepatology, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, 145 Middle Shandong Road, Shanghai, 200001, China

maxiongmd@hotmail.com

Autoimmune liver diseases Nonalcoholic fatty liver disease

Xiong Ma, MD, PhD earned his under-graduated degree from Zhenjiang Medical College in 1991 and received his doctorate degree from Shanghai Jiao Tong University School of Medicine in 2001. He is a member of the Shanghai Society of Hepatology, the Vice-chief member of the Chinese Society of Hepatology Young Member Board. He serves as Director of Shanghai Autoimmune Liver Disease Group. He became a member of International Autoimmune Hepatitis Group since 2011. Dr Ma’s research interests are mainly focused on autoimmune liver diseases and nonalcoholic fatty liver disease. He has received 4 grants from the National Natural Science Foundation of China, and the National Distinguished Young Scholarship in 2013

Yan Gong

Zhongnan Hospital, Wuhan University, Wuhan, China

yan.gong@whu.edu.cn

Lipid metabolism Tumor angiogenesis Tumor immunity

Dr. Yan Gong is engaged in basic research on angiogenesis, lipid metabolism and tumor immunity in Zhongnan Hospital of Wuhan University. He graduated from University of Maine, and got postdoctoral training at Boston Children’s Hospital, Harvard Medical School. He participated in the establishment of Human Genetics Resource Preservation Center of Hubei Province and Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center. Dr. Gong published more than 100 scientific papers in journals including by not limited to Angiogenesis, Metabolism, Cancer Letters. He has been supported by National Natural Science Foundation of China, National Key Research and Development Program of China, and Key Research and Development Program of Hubei Province.

Yufeng Zhou

School of Biomedical Engineering, Chongqing Meddical University, Chongqing, China

yufeng.zhou@cqmu.edu.cn

Shock wave lithotripsy Sonothrombolysis Ultrasound-mediated drug delivery

Yufeng Zhou got his B.S. (1996) and M.S. (1999) degrees from the National Key Lab of Modern Acoustics, Institute of Acoustics, Nanjing University, China. He obtained his Ph.D. degree from Department of mechanical engineering and materials science at Duke University, majored in Bioacoustics in 2003.

Dr. Zhou worked at Duke University between 2003 and 2006, at ImaRx Therapeutics Inc in 2006, at the University of Washington from 2006 to 2010, and at Nanyang Technological University from 2010 to 2020. Since 2021, he joined Chongqing Medical University as a professor at the College of biomedical engineering, State Key Laboratory of Ultrasound in Medicine and Biology, National Engineering Research Center of Ultrasound Medicine. His recent research interests are biomedical ultrasound in therapy and diagnosis, nondestructive evaluation and testing, and acoustics.

Yuxia Luan

Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China

yuxialuan@sdu.edu.cn

Drug delivery Immunotherapy Hydrogel Nanomedicine Photodynamic therapy Prodrugs

Prof. Yuxia Luan studied in Shandong University for her PhD. Her postdoctoral study was performed at University of Montpellier II and Technical University of Munich.

Prof. Yuxia Luan has authored more than 80 high-impact papers published in journals including but not limited to Small, Journal of Colloid and Interface Science, Biomaterials, International Journal of Nanomedicine, Acta Biomaterialia, Journal of Controlled Release.

Zheng Zhang

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing, China

zhangzheng1975@aliyun.com

Hepatology

Dr. Zheng Zhang, Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University. Clinical expertise in the diagnosis and treatment of gastroenterology diseases, such as reflux esophagitis, esophageal ulcer, chronic gastritis, gastric ulcer, duodenal ulcer, esophagofundus varices, gastrointestinal early cancer, colon infection.

Zhongwei Gu

Functional and Molecular Imaging Key Laboratory of Sichuan Province, Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, China

zwgu@scu.edu.cn

Drug delivery Pharmacology and toxicology Nanomedicine

Dr. Zhongwei Gu, Chinese Academy of Medical Sciences, Chengdu, China. His study on Biochemistry is mostly dedicated to connecting different topics, such as In vitro and Gene. His Immunology study frequently draws connections to other fields, such as Immune system, Antigen, Antibody and Adjuvant. Dr. Gu is involved in relevant fields of research such as Drug and Bioavailability in the domain of Pharmacology. Dr. Gu undertakes interdisciplinary study in the fields of Drug and Pharmacology through his works.

Byron Baron

Centre for Molecular Medicine and Biobanking, Faculty of Medicine and Surgery, University of Malta, Msida, Malta

byron.baron@um.edu.mt

Proteomics Molecular and cell biology

Prof. Byron Baron is a biochemist specialising in Proteomics, with a keen interest in methylation. He is an an associate professor with the Centre of Molecular Medicine and Biobanking of the University of Malta. His research interests span a broad range of topics with the main ones being colorectal cancer, chemoresistance, mesenchymal stem cell applications, neuronal differentiation, methyltransfrase interactions, mass spectrometry, proteomic method development, agrichemical bioaccumulation and sustainable agriculture. His research activities focus on answering basic science questions which are of clinical or environmental relevance, doing research with both in-vitro models and patient or donor material to generate 2D and 3D organoid cell cultures to which a number of protein analysis techniques are applied.

Ileana Terruzzi

Department of Biomedical Sciences for Health, University of Milan, Milan, Italy

Ileana.Terruzzi@unimi.it

Metabolism and metabolic diseases Physiology Molecular and cell biology

Dr. Ileana Terruzzi, Associate Professor, Department of Biomedical Sciences for Health. San Raffaele Scientific Institute, Division of Metabolic and Cardiovascular Sciences. Her research interests focus on Metabolism, Nutrigenomics and Cellular Differentiation Unit.

Junfeng Wang

Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands

j.wang-4@umcutrecht.nl

Biostatistics, bioinformatics, epidemiology

Dr. Junfeng Wang, researcher, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University. Next Generation Health Technology Assessment to support patientcentred, societally oriented, real-time decision-making on access to and reimbursement for health technologies throughout Europe (HTx). His research interests focus on Methods and Statistics, Biostatistics, Clinical Epidemiology, Survival Analysis, Statistical Meta-Analysis, Health Economics.

Tiangang Li

Department of Pharmacology, Toxicology & Therapeutics, Kansas University Medical Center, University of Kansas, Kansas City, KA, USA

tli@kumc.edu

Hepatology Metabolism and metabolic diseases

Dr. Tiangang Li, Professor of Physiology, Harold Hamm Chair for Adult Diabetes Research Member, Harold Hamm Diabetes Center. A major focus of his lab is to investigate how modulating the enterohepatic bile acid signaling impacts the complex metabolic network via distinct mechanism of actions. Through these studies, they hope to better understand the pathophysiological function of bile acids and to help establish the molecular basis for developing effective bile acid-based therapies. They address these questions by employing experimental mouse models through viral vector-mediated liver-specific gene delivery, tissue-specific genetic knockout, and pharmacological treatment approaches and a combination of physiological, molecular cell biology techniques and unbiased transcriptomics and metabolomics approaches.

Walfre Franco

Department of Biomedical Engineering, University of Massachusetts, Lowell, MA, USA

Walfre_Franco@uml.edu

Biomedical engineering Biophysics Engineering

Dr. Walfre Franco is an Assistant Professor of Biomedical Engineering at the University of Massachusetts, Lowell. Before joining UMass Lowell, Franco was an Assistant Professor in the Department of Dermatology at Harvard Medical School (HMS) and an Assistant in Biomedical Engineering at the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH). Prof. Franco has led the translation of medical devices from concept to commercialization in academic and industrial settings. Prof. Franco's research initiatives span the design, development, and fabrication of devices, sensors, and computational tools for solving health-related problems.